Epidemiological Challenges in Rare Bleeding Disorders: FVIII Inhibitor Incidence in Haemophilia A Patients-A Known Issue of Unknown Origin.

Keipert, Christine; Drechsel-Bäuerle, Ursula; Oberle, Doris; Müller-Olling, Mirco; Hilger, Anneliese

Keipert, Christine; Drechsel-Bäuerle, Ursula; Oberle, Doris; Müller-Olling, Mirco; Hilger, Anneliese.

Afiliación

Keipert C; German Haemophilia Registry, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Drechsel-Bäuerle U; Safety of Medicinal Products and Medical Devices, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Oberle D; Safety of Medicinal Products and Medical Devices, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Müller-Olling M; Hematology and Transfusion Medicine, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.
Hilger A; Hematology and Transfusion Medicine, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, 63225 Langen, Germany.

Int J Environ Res Public Health ; 18(1)2020 12 30.

Article en En | MEDLINE | ID: mdl-33396748

Asunto(s)

Hemofilia A; Alemania/epidemiología; Hemofilia A/tratamiento farmacológico; Hemofilia A/epidemiología; Hemofilia A/fisiopatología; Humanos; Incidencia; Enfermedades Raras/epidemiología; Sistema de Registros/estadística & datos numéricos

Palabras clave

epidemiology; haemophilia A; inhibitor development; rare diseases

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hemofilia A Tipo de estudio: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Int J Environ Res Public Health Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google